Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14861030 | 0.81 | CES2 (0.53) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL194549 | 0.80 | MEN1 (0.52) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL2296967 | 0.79 | MEN1 (0.48) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL2930719 | 0.76 | HDAC1 (0.59) | MEN1KMT2AKDM4ELMNANPC1 | |
| SCHEMBL29987428 | 0.76 | MEN1 (0.72) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL7432584 | 0.76 | ALDH1A1 (0.50) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL2292351 | 0.76 | CES2 (0.55) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL30949051 | 0.75 | TGM2 (0.53) | RAB9A | |
| Hydrochloric Acid SCHEMBL15973303 | 0.74 | CES2 (0.53) | MEN1KMT2AHPGDKDM4EMAPT | |
| SCHEMBL2558553 | 0.74 | CES2 (0.57) | MEN1KMT2AHPGDKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732550-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MITI (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-0922715-B1 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY IND SCIENCE TECHN (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-6858694-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 2005-02-22 | — | — | US | disclosed |
| US-6852819-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MITI (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20040223947-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
| US-20020188084-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| EP-0922715-A2 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | CREB1, STIM2, GABRE | MEN1 274/4885KMT2A 1868/4885HPGD 357/4885 |
| US-20040223947-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | ACMSD, ADSL, CREB1 | MEN1 781/4885KMT2A 1326/4885HPGD 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.